Boxer Capital Management, LLC
Filing Date
Global Rank
#2,089
/ 8,605
▲ 791
· as of Mar 2026
Top Industry
Biotechnology
98.2%
3Y Alpha vs SPY
+109.5%
Period ended 3 months ago
Filed May 15, 2026 · 55d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+217.2%
SPY
+24.4%
Annualised alpha
+111.7%
Max drawdown
−34.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
52 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
30.2%
+8.2 pts
Top 5
50.6%
+3.0 pts
Top 10
64.0%
−0.9 pts
HHI
1,111
Diversified+343
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $750,964,214 |
| Consumer Defensive | 0.3% | $2,354,148 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PGEN | Precigen, Inc. | +2,125,000 | 3,500,000 | $13,545,000 | |
| VIR | Vir Biotechnology, Inc. | +1,241,000 | 1,866,000 | $16,719,360 | |
| ZURA | Zura Bio Ltd | +850,000 | 900,000 | $5,355,000 | |
| REPL | Replimune Group, Inc. | +425,000 | 1,175,000 | $8,988,750 | |
| QURE | uniQure N.V. | +372,000 | 662,000 | $10,823,700 | |
| SRZN | Surrozen, Inc./DE | +350,168 | 766,318 | $22,322,843 | |
| CLNN | Clene Inc. | +277,778 | 477,515 | $2,354,148 | |
| CAPR | Capricor Therapeutics, Inc. | +265,000 | 590,000 | $17,936,000 | |
| KOD | Kodiak Sciences Inc. | +225,000 | 1,361,000 | $51,881,320 | |
| RVMD | Revolution Medicines, Inc. | +100,000 | 500,000 | $48,625,000 | |
| ABVX | Abivax S.A. | +75,000 | 200,000 | $22,270,000 | |
| KPTI | Karyopharm Therapeutics Inc. | +50,000 | 302,536 | $1,685,125 | |
| AVTX | Avalo Therapeutics, Inc. | +25,000 | 300,000 | $4,479,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 325,000 | $18,885,750 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 1,100,000 | $16,093,000 | |
| DFTX | Definium Therapeutics, Inc. | 598,500 | $11,311,650 | |
| IRD | Opus Genetics, Inc. | 2,250,000 | $10,237,500 | |
| CORT | Corcept Therapeutics Inc | 250,000 | $10,077,500 | |
| SLNO | Soleno Therapeutics Inc | 200,000 | $6,696,000 | |
| ALLO | Allogene Therapeutics, Inc. | 2,725,000 | $6,649,000 | |
| RLMD | Relmada Therapeutics, Inc. | 842,106 | $5,861,057 | |
| OCUL | Ocular Therapeutix, Inc | 350,000 | $2,964,500 | |
| ANTX | AN2 Therapeutics, Inc. | 749,035 | $2,561,699 | |
| ORIC | Oric Pharmaceuticals, Inc. | 176,500 | $2,236,255 | |
| RGNX | REGENXBIO Inc. | 15,000 | $125,700 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CBIO | Crescent Biopharma, Inc. | 453,686 | $5,380,715 | |
| No positions match the current search. | ||||
52 positions ·
$753,318,362 total
· as of Mar 31, 2026
Showing 1–50
of 52 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Held | 10,876,219 | $227,530,501 | 30.20% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 1,361,000 | $51,881,320 | 6.89% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 500,000 | $48,625,000 | 6.45% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 329,100 | $27,410,739 | 3.64% | |
| CELC |
Celcuity Inc.
Healthcare
|
Held | 225,000 | $25,681,500 | 3.41% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Added | 766,318 | $22,322,843 | 2.96% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 200,000 | $22,270,000 | 2.96% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Held | 375,000 | $19,770,000 | 2.62% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
NEW | 325,000 | $18,885,750 | 2.51% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Added | 590,000 | $17,936,000 | 2.38% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 170,000 | $17,918,000 | 2.38% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
Added | 1,866,000 | $16,719,360 | 2.22% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,100,000 | $16,093,000 | 2.14% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 46,457 | $14,967,980 | 1.99% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Held | 200,000 | $13,626,000 | 1.81% | |
| PGEN |
Precigen, Inc.
Healthcare
|
Added | 3,500,000 | $13,545,000 | 1.80% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 598,500 | $11,311,650 | 1.50% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Held | 800,000 | $11,120,000 | 1.48% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 662,000 | $10,823,700 | 1.44% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
NEW | 2,250,000 | $10,237,500 | 1.36% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
NEW | 250,000 | $10,077,500 | 1.34% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Held | 500,000 | $8,990,000 | 1.19% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Added | 1,175,000 | $8,988,750 | 1.19% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Held | 225,000 | $8,660,250 | 1.15% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Held | 4,799,875 | $8,399,781 | 1.12% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 200,000 | $6,696,000 | 0.89% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
NEW | 2,725,000 | $6,649,000 | 0.88% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 100,000 | $6,591,000 | 0.87% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 494,000 | $6,451,640 | 0.86% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Held | 70,000 | $5,891,900 | 0.78% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 842,106 | $5,861,057 | 0.78% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 900,000 | $5,355,000 | 0.71% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 275,000 | $5,126,000 | 0.68% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 300,000 | $4,479,000 | 0.59% | |
| INO |
Inovio Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,370,122 | $4,124,012 | 0.55% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Held | 75,000 | $3,615,000 | 0.48% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Held | 150,000 | $3,264,000 | 0.43% | |
| HELP |
Cybin Inc.
Healthcare
|
Reduced | 640,000 | $3,072,000 | 0.41% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
NEW | 350,000 | $2,964,500 | 0.39% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
NEW | 749,035 | $2,561,699 | 0.34% | |
| CLNN |
Clene Inc.
Consumer Defensive
|
Added | 477,515 | $2,354,148 | 0.31% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
NEW | 176,500 | $2,236,255 | 0.30% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Held | 300,000 | $2,160,000 | 0.29% | |
| IVVD |
Invivyd, Inc.
Healthcare
|
Held | 1,500,000 | $1,950,000 | 0.26% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 70,000 | $1,726,200 | 0.23% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
Added | 302,536 | $1,685,125 | 0.22% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Held | 100,000 | $1,550,000 | 0.21% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Held | 150,000 | $1,350,000 | 0.18% | |
| MIST |
Milestone Pharmaceuticals Inc.
Healthcare
|
Held | 666,666 | $793,332 | 0.11% | |
| PEPG |
PepGen Inc.
Healthcare
|
Reduced | 272,892 | $483,018 | 0.06% |